The CHILD Cohort COVID-19 Add-On Study (NCT05234359) | Clinical Trial Compass
CompletedNot Applicable
The CHILD Cohort COVID-19 Add-On Study
Canada5,385 participantsStarted 2020-10-06
Plain-language summary
The objective of this study is to determine the prevalence and transmission of SARS-CoV-2 infection among Canadian children and parents in the CHILD cohort, identify predictors of infection susceptibility and severity, and understand the health and psychosocial impacts of the COVID-19 pandemic on CHILD families.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All study participants enrolled in the original CHILD Cohort study are eligible for this add-on study
* Individuals living in the same household as study participants enrolled in the original CHILD Cohort Study are also eligible for this add-on study
Exclusion Criteria:
* CHILD Cohort Study participants who have been previously withdrawn from the study are not eligible for this add-on study
* CHILD Cohort Study participants who have not agreed to future contact by the study team are not eligible for this add-on study
* Participants (with the exception of children) who are not able to provide consent on their own behalf are not eligible for this add-on study
* Participants (with the exception of children) who are not able to read, write and understand English are not eligible for this add-on study
* Participants residing outside of Canada will not be participating in the sample collection component of this study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Real-Time data on SARS-CoV-2 infection, severity, transmission and immune response
Timeframe: Biweekly, up to 70 weeks from Dec 2020 through Mar 2022
2
Identify biological and sociodemographic predictors of SARS-CoV-2 infection
Timeframe: Quarterly (once every 3 months - total duration 12 months), from Dec 2020 through Mar 2022. Baseline survey (Dec - May 2021); Follow-up 1 Survey (July - Aug 2021); Follow-up 2 Survey (Oct - Dec 2021); Follow-up 3 (Jan - Mar 2022)
3
Understand the psychosocial, health and equity impacts of the COVID-19 pandemic and its management on CHILD families, and identify equity impacts
Timeframe: Quarterly (once every 3 months - total duration 12 months), from Dec 2020 through Mar 2022. Baseline survey (Dec - May 2021); Follow-up 1 Survey (July - Aug 2021); Follow-up 2 Survey (Oct - Dec 2021); Follow-up 3 (Jan - Mar 2022)
4
Determine pre-pandemic immune profile of CHILD index children